
1. Technology overview
Miracle is a San Francisco company (address 2261 Market Street) in Y Combinator's Winter 2023 batch, founded in 2022. It connects clinical trial systems to give clinical-stage teams real-time study oversight.
The platform pulls data from EDC, IRT, labs, CTMS and CRO reports, automates spreadsheet trackers and reconciliation, and raises study risks earlier.
2. Highlighted features & specifications
- Data connection: EDC, IRT/RTSM, labs, CTMS and CRO reports.
- Tracker automation: replaces recurring spreadsheet updates.
- Real-time alerts: flags risks and discrepancies.
- Reconciliation: automated data reconciliation.
- Case studies: published biopharma partnerships.
3. Potential application
A CRO in Vietnam could consolidate trial data from several systems. A hospital research unit could track site metrics.
4. Benefits
Spreadsheet trackers are replaced by automated workflows. Study risks surface earlier through real-time alerts. The site says go-live takes days, not weeks.
5. Market trends & opportunities
Biopharma sponsors need real-time trial oversight across many systems. Vietnamese CROs and trial sites are growing in number.
6. Other information
YC W23. Also published a 2025 year-in-review post (2025-12).
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































